J S Redding

833 total citations
16 papers, 716 citations indexed

About

J S Redding is a scholar working on Infectious Diseases, Molecular Medicine and Microbiology. According to data from OpenAlex, J S Redding has authored 16 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Molecular Medicine and 7 papers in Microbiology. Recurrent topics in J S Redding's work include Antibiotic Resistance in Bacteria (7 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Bacterial Infections and Vaccines (6 papers). J S Redding is often cited by papers focused on Antibiotic Resistance in Bacteria (7 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Bacterial Infections and Vaccines (6 papers). J S Redding collaborates with scholars based in United States. J S Redding's co-authors include L A Maher, J H Jorgensen, A W Howell, Gary V. Doern, J. H. Jorgensen, David A. Preston, C Thornsberry, James E. Johnson, Clyde Thornsberry and Sharon A. Crawford and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and European Journal of Clinical Microbiology & Infectious Diseases.

In The Last Decade

J S Redding

15 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J S Redding United States 11 502 255 239 238 136 16 716
A W Howell United States 13 506 1.0× 213 0.8× 254 1.1× 265 1.1× 109 0.8× 17 752
L A Maher United States 13 636 1.3× 310 1.2× 310 1.3× 288 1.2× 147 1.1× 18 897
Yolanda Mauriz United States 6 576 1.1× 146 0.6× 310 1.3× 291 1.2× 179 1.3× 7 765
G V Doern United States 11 810 1.6× 269 1.1× 355 1.5× 345 1.4× 305 2.2× 12 1.1k
Anne Windau United States 14 519 1.0× 234 0.9× 165 0.7× 243 1.0× 169 1.2× 21 800
Renée S. Blosser-Middleton United States 14 277 0.6× 86 0.3× 164 0.7× 167 0.7× 119 0.9× 17 460
E Vallée France 16 419 0.8× 80 0.3× 307 1.3× 266 1.1× 157 1.2× 31 642
Dianne B. Hoellman United States 16 323 0.6× 86 0.3× 308 1.3× 264 1.1× 216 1.6× 23 635
Linda M. Kelly United States 13 320 0.6× 77 0.3× 251 1.1× 179 0.8× 160 1.2× 17 494
A. Frémaux France 13 413 0.8× 168 0.7× 145 0.6× 72 0.3× 123 0.9× 32 506

Countries citing papers authored by J S Redding

Since Specialization
Citations

This map shows the geographic impact of J S Redding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J S Redding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J S Redding more than expected).

Fields of papers citing papers by J S Redding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J S Redding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J S Redding. The network helps show where J S Redding may publish in the future.

Co-authorship network of co-authors of J S Redding

This figure shows the co-authorship network connecting the top 25 collaborators of J S Redding. A scholar is included among the top collaborators of J S Redding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J S Redding. J S Redding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Jorgensen, J H, Gary V. Doern, L A Maher, A W Howell, & J S Redding. (1990). Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrobial Agents and Chemotherapy. 34(11). 2075–2080. 258 indexed citations
2.
Jorgensen, J H, J S Redding, & L A Maher. (1989). Antibacterial activity of the new glycopeptide antibiotic SKF104662. Antimicrobial Agents and Chemotherapy. 33(4). 560–561. 7 indexed citations
3.
Jorgensen, J H, Gary V. Doern, Clyde Thornsberry, et al.. (1988). Susceptibility of multiply resistant Haemophilus influenzae to newer antimicrobial agents. Diagnostic Microbiology and Infectious Disease. 9(1). 27–32. 30 indexed citations
4.
Doern, Gary V., J. H. Jorgensen, C Thornsberry, et al.. (1988). National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae. Antimicrobial Agents and Chemotherapy. 32(2). 180–185. 152 indexed citations
5.
Jorgensen, J H, et al.. (1988). Salt-supplemented medium for testing methicillin-resistant staphylococci with newer beta-lactams. Journal of Clinical Microbiology. 26(9). 1675–1678. 10 indexed citations
6.
Jorgensen, J H, J S Redding, & L A Maher. (1988). Influence of storage and susceptibility test conditions on stability and activity of LY163892 and four other cephalosporins. Antimicrobial Agents and Chemotherapy. 32(10). 1477–1480. 13 indexed citations
7.
Jorgensen, J H, L A Maher, & J S Redding. (1988). Disk diffusion interpretive criteria for extended-spectrum cephalosporins with Haemophilus influenzae. Journal of Clinical Microbiology. 26(9). 1887–1889. 9 indexed citations
8.
Jorgensen, J H, J S Redding, L A Maher, & A W Howell. (1987). Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae. Journal of Clinical Microbiology. 25(11). 2105–2113. 149 indexed citations
9.
Jorgensen, J H, L A Maher, & J S Redding. (1987). In vitro activity of LY146032 (Daptomycin) against selected aerobic bacteria. European Journal of Clinical Microbiology & Infectious Diseases. 6(1). 91–96. 21 indexed citations
10.
Jorgensen, J. H., J S Redding, & A W Howell. (1986). In vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) against clinical isolates of Haemophilus influenzae. Antimicrobial Agents and Chemotherapy. 29(5). 921–922. 13 indexed citations
11.
Jorgensen, J. H., J S Redding, & A W Howell. (1986). Comparative activities of LY 164846 and other orally administered beta-lactam antibiotics against Haemophilus influenzae. Antimicrobial Agents and Chemotherapy. 29(6). 1090–1091. 2 indexed citations
12.
Jorgensen, J. H., J S Redding, & A W Howell. (1986). Evaluation of broth disk elution methods for susceptibility testing of anaerobic bacteria with the newer beta-lactam antibiotics. Journal of Clinical Microbiology. 23(3). 545–550. 17 indexed citations
13.
Jorgensen, J H, et al.. (1984). Rapid recognition of methicillin-resistant Staphylococcus aureus by use of automated test systems. Journal of Clinical Microbiology. 20(3). 430–433. 15 indexed citations
14.
Jorgensen, J H, et al.. (1984). Collaborative evaluation of the Abbott Avantage system for identification of frequently isolated nonfermentative or oxidase-positive gram-negative bacilli. Journal of Clinical Microbiology. 20(5). 899–904. 5 indexed citations
15.
Johnson, James E., et al.. (1983). Comparison ofTwoAutomated Instrument Systems forRapid Susceptibility Testing ofGram-Negative Bacilli.
16.
Johnson, James E., et al.. (1983). Comparison of two automated instrument systems for rapid susceptibility testing of gram-negative bacilli. Journal of Clinical Microbiology. 18(6). 1301–1309. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A W Howell Breakdown of academic impact, for papers by L A Maher Breakdown of academic impact, for papers by Yolanda Mauriz Breakdown of academic impact, for papers by G V Doern Breakdown of academic impact, for papers by Anne Windau Breakdown of academic impact, for papers by Renée S. Blosser-Middleton Breakdown of academic impact, for papers by E Vallée Breakdown of academic impact, for papers by Dianne B. Hoellman Breakdown of academic impact, for papers by Linda M. Kelly Breakdown of academic impact, for papers by A. Frémaux
Rankless by CCL
2026